Applied therapeutics reports q3 loss per share of $0.63

Applied therapeutics reports third quarter 2019 financial results.q3 loss per share $0.63.q3 earnings per share estimate $-0.49 -- refinitiv ibes data.cash and cash equivalents and short-term investments totaled $33.0 million as of september 30, 2019.remain on track to report pivotal data on galactosemia program by year end.qtrly research and development expenses for were $7.5 million versus $2.7 million.
APLT Ratings Summary
APLT Quant Ranking